In this interview with CEOCFO Magazine, Dr. John M. Burke, Co-founder, President and CEO at Applied BioMath discusses how Applied BioMath is modernizing drug discovery, drug development, and clinical trials by applying quantitative systems pharmacology (QSP), mathematical modeling and machine learning techniques to drug research and development. "We help predict the failures much earlier - with the killer experiment, to help reduce late stage attrition rates," said Dr. John Burke. "This helps our collaborators prioritize their resources and their experiments."